img

Global Amino Acid Metabolism Disorder Drug Market Report, History and Forecast 2024-2034, Breakdown Data by Companies, Key Regions, Types and Application


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Amino Acid Metabolism Disorder Drug Market Report, History and Forecast 2024-2034, Breakdown Data by Companies, Key Regions, Types and Application

Amino Acid Metabolism Disorder Drug report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Amino Acid Metabolism Disorder Drug market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Phenylketonuria and Maple Syrup Urine Disease are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Amino Acid Metabolism Disorder Drug industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Amino Acid Metabolism Disorder Drug key companies include GlaxoSmithKline, Pfizer, AMINO, Merck, Recordati, DSM, Sanofi, Kyowa Hakko Kirin and BioMarin, etc. GlaxoSmithKline, Pfizer, AMINO are top 3 players and held % share in total in 2022.
Amino Acid Metabolism Disorder Drug can be divided into Arginine, Folic Acid, Vitamin B6 & B12 and Thiamine, etc. Arginine is the mainstream product in the market, accounting for % share globally in 2022.
Amino Acid Metabolism Disorder Drug is widely used in various fields, such as Phenylketonuria, Maple Syrup Urine Disease, Argininosuccinic Acidemia and Citrullinemia, etc. Phenylketonuria provides greatest supports to the Amino Acid Metabolism Disorder Drug industry development. In 2022, global % share of Amino Acid Metabolism Disorder Drug went into Phenylketonuria filed.
Report Scope
This report, based on historical analysis (2024-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Amino Acid Metabolism Disorder Drug market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report



By Company


GlaxoSmithKline
Pfizer
AMINO
Merck
Recordati
DSM
Sanofi
Kyowa Hakko Kirin
BioMarin
Swedish Orphan Biovitrum
Shine Star (Hubei) Biological Engineering
Segment by Type
Arginine
Folic Acid
Vitamin B6 & B12
Thiamine
Vitamin D
Betaine
Carglumic Acid
Sapropterin Dihydrochloride
Others

Segment by Application


Phenylketonuria
Maple Syrup Urine Disease
Argininosuccinic Acidemia
Citrullinemia
Homocystinuria
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries

Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia

Latin America
Mexico
Brazil

Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Amino Acid Metabolism Disorder Drug market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2024-2024, 2024-2034).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, Amino Acid Metabolism Disorder Drug introduction, etc. Amino Acid Metabolism Disorder Drug Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12Mr Accuracy reports’s Conclusions of Amino Acid Metabolism Disorder Drug market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by Mr Accuracy reports.

Table of Content

1 Market Overview of Amino Acid Metabolism Disorder Drug
1.1 Amino Acid Metabolism Disorder Drug Market Overview
1.1.1 Amino Acid Metabolism Disorder Drug Product Scope
1.1.2 Amino Acid Metabolism Disorder Drug Market Status and Outlook
1.2 Global Amino Acid Metabolism Disorder Drug Market Size Overview by Region 2024 VS 2022 VS 2034
1.3 Global Amino Acid Metabolism Disorder Drug Market Size by Region (2024-2034)
1.4 Global Amino Acid Metabolism Disorder Drug Historic Market Size by Region (2024-2024)
1.5 Global Amino Acid Metabolism Disorder Drug Market Size Forecast by Region (2024-2034)
1.6 Key Regions, Amino Acid Metabolism Disorder Drug Market Size (2024-2034)
1.6.1 North America Amino Acid Metabolism Disorder Drug Market Size (2024-2034)
1.6.2 Europe Amino Acid Metabolism Disorder Drug Market Size (2024-2034)
1.6.3 Asia-Pacific Amino Acid Metabolism Disorder Drug Market Size (2024-2034)
1.6.4 Latin America Amino Acid Metabolism Disorder Drug Market Size (2024-2034)
1.6.5 Middle East & Africa Amino Acid Metabolism Disorder Drug Market Size (2024-2034)
2 Amino Acid Metabolism Disorder Drug Market by Type
2.1 Introduction
2.1.1 Arginine
2.1.2 Folic Acid
2.1.3 Vitamin B6 & B12
2.1.4 Thiamine
2.1.5 Vitamin D
2.1.6 Betaine
2.1.7 Carglumic Acid
2.1.8 Sapropterin Dihydrochloride
2.1.9 Others
2.2 Global Amino Acid Metabolism Disorder Drug Market Size by Type: 2024 VS 2022 VS 2034
2.2.1 Global Amino Acid Metabolism Disorder Drug Historic Market Size by Type (2024-2024)
2.2.2 Global Amino Acid Metabolism Disorder Drug Forecasted Market Size by Type (2024-2034)
2.3 Key Regions Market Size by Type
2.3.1 North America Amino Acid Metabolism Disorder Drug Revenue Breakdown by Type (2024-2034)
2.3.2 Europe Amino Acid Metabolism Disorder Drug Revenue Breakdown by Type (2024-2034)
2.3.3 Asia-Pacific Amino Acid Metabolism Disorder Drug Revenue Breakdown by Type (2024-2034)
2.3.4 Latin America Amino Acid Metabolism Disorder Drug Revenue Breakdown by Type (2024-2034)
2.3.5 Middle East and Africa Amino Acid Metabolism Disorder Drug Revenue Breakdown by Type (2024-2034)
3 Amino Acid Metabolism Disorder Drug Market Overview by Application
3.1 Introduction
3.1.1 Phenylketonuria
3.1.2 Maple Syrup Urine Disease
3.1.3 Argininosuccinic Acidemia
3.1.4 Citrullinemia
3.1.5 Homocystinuria
3.2 Global Amino Acid Metabolism Disorder Drug Market Size by Application: 2024 VS 2022 VS 2034
3.2.1 Global Amino Acid Metabolism Disorder Drug Historic Market Size by Application (2024-2024)
3.2.2 Global Amino Acid Metabolism Disorder Drug Forecasted Market Size by Application (2024-2034)
3.3 Key Regions Market Size by Application
3.3.1 North America Amino Acid Metabolism Disorder Drug Revenue Breakdown by Application (2024-2034)
3.3.2 Europe Amino Acid Metabolism Disorder Drug Revenue Breakdown by Application (2024-2034)
3.3.3 Asia-Pacific Amino Acid Metabolism Disorder Drug Revenue Breakdown by Application (2024-2034)
3.3.4 Latin America Amino Acid Metabolism Disorder Drug Revenue Breakdown by Application (2024-2034)
3.3.5 Middle East and Africa Amino Acid Metabolism Disorder Drug Revenue Breakdown by Application (2024-2034)
4 Amino Acid Metabolism Disorder Drug Competition Analysis by Players
4.1 Global Amino Acid Metabolism Disorder Drug Market Size by Players (2024-2024)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Amino Acid Metabolism Disorder Drug as of 2022)
4.3 Date of Key Players Enter into Amino Acid Metabolism Disorder Drug Market
4.4 Global Top Players Amino Acid Metabolism Disorder Drug Headquarters and Area Served
4.5 Key Players Amino Acid Metabolism Disorder Drug Product Solution and Service
4.6 Competitive Status
4.6.1 Amino Acid Metabolism Disorder Drug Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 GlaxoSmithKline
5.1.1 GlaxoSmithKline Profile
5.1.2 GlaxoSmithKline Main Business
5.1.3 GlaxoSmithKline Amino Acid Metabolism Disorder Drug Products, Services and Solutions
5.1.4 GlaxoSmithKline Amino Acid Metabolism Disorder Drug Revenue (US$ Million) & (2024-2024)
5.1.5 GlaxoSmithKline Recent Developments
5.2 Pfizer
5.2.1 Pfizer Profile
5.2.2 Pfizer Main Business
5.2.3 Pfizer Amino Acid Metabolism Disorder Drug Products, Services and Solutions
5.2.4 Pfizer Amino Acid Metabolism Disorder Drug Revenue (US$ Million) & (2024-2024)
5.2.5 Pfizer Recent Developments
5.3 AMINO
5.3.1 AMINO Profile
5.3.2 AMINO Main Business
5.3.3 AMINO Amino Acid Metabolism Disorder Drug Products, Services and Solutions
5.3.4 AMINO Amino Acid Metabolism Disorder Drug Revenue (US$ Million) & (2024-2024)
5.3.5 Merck Recent Developments
5.4 Merck
5.4.1 Merck Profile
5.4.2 Merck Main Business
5.4.3 Merck Amino Acid Metabolism Disorder Drug Products, Services and Solutions
5.4.4 Merck Amino Acid Metabolism Disorder Drug Revenue (US$ Million) & (2024-2024)
5.4.5 Merck Recent Developments
5.5 Recordati
5.5.1 Recordati Profile
5.5.2 Recordati Main Business
5.5.3 Recordati Amino Acid Metabolism Disorder Drug Products, Services and Solutions
5.5.4 Recordati Amino Acid Metabolism Disorder Drug Revenue (US$ Million) & (2024-2024)
5.5.5 Recordati Recent Developments
5.6 DSM
5.6.1 DSM Profile
5.6.2 DSM Main Business
5.6.3 DSM Amino Acid Metabolism Disorder Drug Products, Services and Solutions
5.6.4 DSM Amino Acid Metabolism Disorder Drug Revenue (US$ Million) & (2024-2024)
5.6.5 DSM Recent Developments
5.7 Sanofi
5.7.1 Sanofi Profile
5.7.2 Sanofi Main Business
5.7.3 Sanofi Amino Acid Metabolism Disorder Drug Products, Services and Solutions
5.7.4 Sanofi Amino Acid Metabolism Disorder Drug Revenue (US$ Million) & (2024-2024)
5.7.5 Sanofi Recent Developments
5.8 Kyowa Hakko Kirin
5.8.1 Kyowa Hakko Kirin Profile
5.8.2 Kyowa Hakko Kirin Main Business
5.8.3 Kyowa Hakko Kirin Amino Acid Metabolism Disorder Drug Products, Services and Solutions
5.8.4 Kyowa Hakko Kirin Amino Acid Metabolism Disorder Drug Revenue (US$ Million) & (2024-2024)
5.8.5 Kyowa Hakko Kirin Recent Developments
5.9 BioMarin
5.9.1 BioMarin Profile
5.9.2 BioMarin Main Business
5.9.3 BioMarin Amino Acid Metabolism Disorder Drug Products, Services and Solutions
5.9.4 BioMarin Amino Acid Metabolism Disorder Drug Revenue (US$ Million) & (2024-2024)
5.9.5 BioMarin Recent Developments
5.10 Swedish Orphan Biovitrum
5.10.1 Swedish Orphan Biovitrum Profile
5.10.2 Swedish Orphan Biovitrum Main Business
5.10.3 Swedish Orphan Biovitrum Amino Acid Metabolism Disorder Drug Products, Services and Solutions
5.10.4 Swedish Orphan Biovitrum Amino Acid Metabolism Disorder Drug Revenue (US$ Million) & (2024-2024)
5.10.5 Swedish Orphan Biovitrum Recent Developments
5.11 Shine Star (Hubei) Biological Engineering
5.11.1 Shine Star (Hubei) Biological Engineering Profile
5.11.2 Shine Star (Hubei) Biological Engineering Main Business
5.11.3 Shine Star (Hubei) Biological Engineering Amino Acid Metabolism Disorder Drug Products, Services and Solutions
5.11.4 Shine Star (Hubei) Biological Engineering Amino Acid Metabolism Disorder Drug Revenue (US$ Million) & (2024-2024)
5.11.5 Shine Star (Hubei) Biological Engineering Recent Developments
6 North America
6.1 North America Amino Acid Metabolism Disorder Drug Market Size by Country (2024-2034)
6.2 United States
6.3 Canada
7 Europe
7.1 Europe Amino Acid Metabolism Disorder Drug Market Size by Country (2024-2034)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Amino Acid Metabolism Disorder Drug Market Size by Region (2024-2034)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Amino Acid Metabolism Disorder Drug Market Size by Country (2024-2034)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Amino Acid Metabolism Disorder Drug Market Size by Country (2024-2034)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Amino Acid Metabolism Disorder Drug Market Dynamics
11.1 Amino Acid Metabolism Disorder Drug Industry Trends
11.2 Amino Acid Metabolism Disorder Drug Market Drivers
11.3 Amino Acid Metabolism Disorder Drug Market Challenges
11.4 Amino Acid Metabolism Disorder Drug Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List

List of Figure

List of Tables
Table 1. Global Market Amino Acid Metabolism Disorder Drug Market Size (US$ Million) Comparison by Region 2024 VS 2022 VS 2034
Table 2. Global Amino Acid Metabolism Disorder Drug Market Size by Region (2024-2024) & (US$ Million)
Table 3. Global Amino Acid Metabolism Disorder Drug Market Size Share by Region (2024-2024)
Table 4. Global Amino Acid Metabolism Disorder Drug Forecasted Market Size by Region (2024-2034) & (US$ Million)
Table 5. Global Amino Acid Metabolism Disorder Drug Forecasted Market Size Share by Region (2024-2034)
Table 6. Global Amino Acid Metabolism Disorder Drug Market Size (US$ Million) by Type: 2024 VS 2022 VS 2034
Table 7. Global Amino Acid Metabolism Disorder Drug Market Size by Type (2024-2024) & (US$ Million)
Table 8. Global Amino Acid Metabolism Disorder Drug Revenue Market Share by Type (2024-2024)
Table 9. Global Amino Acid Metabolism Disorder Drug Forecasted Market Size by Type (2024-2034) & (US$ Million)
Table 10. Global Amino Acid Metabolism Disorder Drug Revenue Market Share by Type (2024-2034)
Table 11. North America Amino Acid Metabolism Disorder Drug Revenue by Type (2024-2024) & (US$ Million)
Table 12. North America Amino Acid Metabolism Disorder Drug Revenue by Type (2024-2034) & (US$ Million)
Table 13. Europe Amino Acid Metabolism Disorder Drug Revenue by Type (2024-2024) & (US$ Million)
Table 14. Europe Amino Acid Metabolism Disorder Drug Revenue by Type (2024-2034) & (US$ Million)
Table 15. Asia-Pacific Amino Acid Metabolism Disorder Drug Revenue by Type (2024-2024) & (US$ Million)
Table 16. Asia-Pacific Amino Acid Metabolism Disorder Drug Revenue by Type (2024-2034) & (US$ Million)
Table 17. Latin America Amino Acid Metabolism Disorder Drug Revenue by Type (2024-2024) & (US$ Million)
Table 18. Latin America Amino Acid Metabolism Disorder Drug Revenue by Type (2024-2034) & (US$ Million)
Table 19. Middle East and Africa Amino Acid Metabolism Disorder Drug Revenue by Type (2024-2024) & (US$ Million)
Table 20. Middle East and Africa Amino Acid Metabolism Disorder Drug Revenue by Type (2024-2034) & (US$ Million)
Table 21. Global Amino Acid Metabolism Disorder Drug Market Size (US$ Million) by Application: 2024 VS 2022 VS 2034
Table 22. Global Amino Acid Metabolism Disorder Drug Market Size by Application (2024-2024) & (US$ Million)
Table 23. Global Amino Acid Metabolism Disorder Drug Revenue Market Share by Application (2024-2024)
Table 24. Global Amino Acid Metabolism Disorder Drug Forecasted Market Size by Application (2024-2034) & (US$ Million)
Table 25. Global Amino Acid Metabolism Disorder Drug Revenue Market Share by Application (2024-2034)
Table 26. North America Amino Acid Metabolism Disorder Drug Revenue by Application (2024-2024) & (US$ Million)
Table 27. North America Amino Acid Metabolism Disorder Drug Revenue by Application (2024-2034) & (US$ Million)
Table 28. Europe Amino Acid Metabolism Disorder Drug Revenue by Application (2024-2024) & (US$ Million)
Table 29. Europe Amino Acid Metabolism Disorder Drug Revenue by Application (2024-2034) & (US$ Million)
Table 30. Asia-Pacific Amino Acid Metabolism Disorder Drug Revenue by Application (2024-2024) & (US$ Million)
Table 31. Asia-Pacific Amino Acid Metabolism Disorder Drug Revenue by Application (2024-2034) & (US$ Million)
Table 32. Latin America Amino Acid Metabolism Disorder Drug Revenue by Application (2024-2024) & (US$ Million)
Table 33. Latin America Amino Acid Metabolism Disorder Drug Revenue by Application (2024-2034) & (US$ Million)
Table 34. Middle East and Africa Amino Acid Metabolism Disorder Drug Revenue by Application (2024-2024) & (US$ Million)
Table 35. Middle East and Africa Amino Acid Metabolism Disorder Drug Revenue by Application (2024-2034) & (US$ Million)
Table 36. Global Amino Acid Metabolism Disorder Drug Revenue (US$ Million) by Players (2024-2024)
Table 37. Global Amino Acid Metabolism Disorder Drug Revenue Market Share by Players (2024-2024)
Table 38. Global Top Players Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Amino Acid Metabolism Disorder Drug as of 2022)
Table 39. Date of Key Players Enter into Amino Acid Metabolism Disorder Drug Market
Table 40. Global Amino Acid Metabolism Disorder Drug Key Players Headquarters and Area Served
Table 41. Amino Acid Metabolism Disorder Drug Product Solution and Service
Table 42. Global Amino Acid Metabolism Disorder Drug Players Market Concentration Ratio (CR5 and HHI)
Table 43. Mergers & Acquisitions, Expansion Plans
Table 44. GlaxoSmithKline Basic Information List
Table 45. GlaxoSmithKline Description and Business Overview
Table 46. GlaxoSmithKline Amino Acid Metabolism Disorder Drug Products, Services and Solutions
Table 47. Revenue (US$ Million) in Amino Acid Metabolism Disorder Drug Business of GlaxoSmithKline (2024-2024)
Table 48. GlaxoSmithKline Recent Developments
Table 49. Pfizer Basic Information List
Table 50. Pfizer Description and Business Overview
Table 51. Pfizer Amino Acid Metabolism Disorder Drug Products, Services and Solutions
Table 52. Revenue (US$ Million) in Amino Acid Metabolism Disorder Drug Business of Pfizer (2024-2024)
Table 53. Pfizer Recent Developments
Table 54. AMINO Basic Information List
Table 55. AMINO Description and Business Overview
Table 56. AMINO Amino Acid Metabolism Disorder Drug Products, Services and Solutions
Table 57. Revenue (US$ Million) in Amino Acid Metabolism Disorder Drug Business of AMINO (2024-2024)
Table 58. AMINO Recent Developments
Table 59. Merck Basic Information List
Table 60. Merck Description and Business Overview
Table 61. Merck Amino Acid Metabolism Disorder Drug Products, Services and Solutions
Table 62. Revenue (US$ Million) in Amino Acid Metabolism Disorder Drug Business of Merck (2024-2024)
Table 63. Merck Recent Developments
Table 64. Recordati Basic Information List
Table 65. Recordati Description and Business Overview
Table 66. Recordati Amino Acid Metabolism Disorder Drug Products, Services and Solutions
Table 67. Revenue (US$ Million) in Amino Acid Metabolism Disorder Drug Business of Recordati (2024-2024)
Table 68. Recordati Recent Developments
Table 69. DSM Basic Information List
Table 70. DSM Description and Business Overview
Table 71. DSM Amino Acid Metabolism Disorder Drug Products, Services and Solutions
Table 72. Revenue (US$ Million) in Amino Acid Metabolism Disorder Drug Business of DSM (2024-2024)
Table 73. DSM Recent Developments
Table 74. Sanofi Basic Information List
Table 75. Sanofi Description and Business Overview
Table 76. Sanofi Amino Acid Metabolism Disorder Drug Products, Services and Solutions
Table 77. Revenue (US$ Million) in Amino Acid Metabolism Disorder Drug Business of Sanofi (2024-2024)
Table 78. Sanofi Recent Developments
Table 79. Kyowa Hakko Kirin Basic Information List
Table 80. Kyowa Hakko Kirin Description and Business Overview
Table 81. Kyowa Hakko Kirin Amino Acid Metabolism Disorder Drug Products, Services and Solutions
Table 82. Revenue (US$ Million) in Amino Acid Metabolism Disorder Drug Business of Kyowa Hakko Kirin (2024-2024)
Table 83. Kyowa Hakko Kirin Recent Developments
Table 84. BioMarin Basic Information List
Table 85. BioMarin Description and Business Overview
Table 86. BioMarin Amino Acid Metabolism Disorder Drug Products, Services and Solutions
Table 87. Revenue (US$ Million) in Amino Acid Metabolism Disorder Drug Business of BioMarin (2024-2024)
Table 88. BioMarin Recent Developments
Table 89. Swedish Orphan Biovitrum Basic Information List
Table 90. Swedish Orphan Biovitrum Description and Business Overview
Table 91. Swedish Orphan Biovitrum Amino Acid Metabolism Disorder Drug Products, Services and Solutions
Table 92. Revenue (US$ Million) in Amino Acid Metabolism Disorder Drug Business of Swedish Orphan Biovitrum (2024-2024)
Table 93. Swedish Orphan Biovitrum Recent Developments
Table 94. Shine Star (Hubei) Biological Engineering Basic Information List
Table 95. Shine Star (Hubei) Biological Engineering Description and Business Overview
Table 96. Shine Star (Hubei) Biological Engineering Amino Acid Metabolism Disorder Drug Products, Services and Solutions
Table 97. Revenue (US$ Million) in Amino Acid Metabolism Disorder Drug Business of Shine Star (Hubei) Biological Engineering (2024-2024)
Table 98. Shine Star (Hubei) Biological Engineering Recent Developments
Table 99. North America Amino Acid Metabolism Disorder Drug Market Size by Country (2024-2024) & (US$ Million)
Table 100. North America Amino Acid Metabolism Disorder Drug Market Size by Country (2024-2034) & (US$ Million)
Table 101. Europe Amino Acid Metabolism Disorder Drug Market Size by Country (2024-2024) & (US$ Million)
Table 102. Europe Amino Acid Metabolism Disorder Drug Market Size by Country (2024-2034) & (US$ Million)
Table 103. Asia-Pacific Amino Acid Metabolism Disorder Drug Market Size Growth Rate (CAGR) by Region (US$ Million): 2024 VS 2022 VS 2034
Table 104. Asia-Pacific Amino Acid Metabolism Disorder Drug Market Size by Region (2024-2024) & (US$ Million)
Table 105. Asia-Pacific Amino Acid Metabolism Disorder Drug Market Size by Region (2024-2034) & (US$ Million)
Table 106. Asia-Pacific Amino Acid Metabolism Disorder Drug Market Share by Region (2024-2024)
Table 107. Asia-Pacific Amino Acid Metabolism Disorder Drug Market Share by Region (2024-2034)
Table 108. Latin America Amino Acid Metabolism Disorder Drug Market Size Growth Rate (CAGR) by Region (US$ Million): 2024 VS 2022 VS 2034
Table 109. Latin America Amino Acid Metabolism Disorder Drug Market Size by Country (2024-2024) & (US$ Million)
Table 110. Latin America Amino Acid Metabolism Disorder Drug Market Size by Country (2024-2034) & (US$ Million)
Table 111. Middle East & Africa Amino Acid Metabolism Disorder Drug Market Size Growth Rate (CAGR) by Region (US$ Million): 2024 VS 2022 VS 2034
Table 112. Middle East & Africa Amino Acid Metabolism Disorder Drug Market Size by Country (2024-2024) & (US$ Million)
Table 113. Middle East & Africa Amino Acid Metabolism Disorder Drug Market Size by Country (2024-2034) & (US$ Million)
Table 114. Amino Acid Metabolism Disorder Drug Market Trends
Table 115. Amino Acid Metabolism Disorder Drug Market Drivers
Table 116. Amino Acid Metabolism Disorder Drug Market Challenges
Table 117. Amino Acid Metabolism Disorder Drug Market Restraints
Table 118. Research Programs/Design for This Report
Table 119. Key Data Information from Secondary Sources
Table 120. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Amino Acid Metabolism Disorder Drug Market Size Year-over-Year 2024-2034 & (US$ Million)
Figure 2. Global Amino Acid Metabolism Disorder Drug Market Size (US$ Million), 2024 VS 2022 VS 2034
Figure 3. Global Amino Acid Metabolism Disorder Drug Market Share by Regions: 2022 VS 2034
Figure 4. Global Amino Acid Metabolism Disorder Drug Forecasted Market Size Share by Region (2024-2034)
Figure 5. North America Amino Acid Metabolism Disorder Drug Market Size Growth Rate (2024-2034) & (US$ Million)
Figure 6. Europe Amino Acid Metabolism Disorder Drug Market Size Growth Rate (2024-2034) & (US$ Million)
Figure 7. Asia-Pacific Amino Acid Metabolism Disorder Drug Market Size Growth Rate (2024-2034) & (US$ Million)
Figure 8. Latin America Amino Acid Metabolism Disorder Drug Market Size Growth Rate (2024-2034) & (US$ Million)
Figure 9. Middle East & Africa Amino Acid Metabolism Disorder Drug Market Size Growth Rate (2024-2034) & (US$ Million)
Figure 10. Product Picture of Arginine
Figure 11. Global Arginine Market Size (US$ Million) & YoY Growth (2024-2034)
Figure 12. Product Picture of Folic Acid
Figure 13. Global Folic Acid Market Size (US$ Million) & YoY Growth (2024-2034)
Figure 14. Product Picture of Vitamin B6 & B12
Figure 15. Global Vitamin B6 & B12 Market Size (US$ Million) & YoY Growth (2024-2034)
Figure 16. Product Picture of Thiamine
Figure 17. Global Thiamine Market Size (US$ Million) & YoY Growth (2024-2034)
Figure 18. Product Picture of Vitamin D
Figure 19. Global Vitamin D Market Size (US$ Million) & YoY Growth (2024-2034)
Figure 20. Product Picture of Betaine
Figure 21. Global Betaine Market Size (US$ Million) & YoY Growth (2024-2034)
Figure 22. Product Picture of Carglumic Acid
Figure 23. Global Carglumic Acid Market Size (US$ Million) & YoY Growth (2024-2034)
Figure 24. Product Picture of Sapropterin Dihydrochloride
Figure 25. Global Sapropterin Dihydrochloride Market Size (US$ Million) & YoY Growth (2024-2034)
Figure 26. Product Picture of Others
Figure 27. Global Others Market Size (US$ Million) & YoY Growth (2024-2034)
Figure 28. Global Amino Acid Metabolism Disorder Drug Market Size Share by Type: 2022 & 2034
Figure 29. North America Amino Acid Metabolism Disorder Drug Revenue Market Share by Type (2024-2034)
Figure 30. Europe Amino Acid Metabolism Disorder Drug Revenue Market Share by Type (2024-2034)
Figure 31. Asia-Pacific Amino Acid Metabolism Disorder Drug Revenue Market Share by Type (2024-2034)
Figure 32. Latin America Amino Acid Metabolism Disorder Drug Revenue Market Share by Type (2024-2034)
Figure 33. Middle East and Africa Amino Acid Metabolism Disorder Drug Revenue Market Share by Type (2024-2034)
Figure 34. Phenylketonuria Market Size (US$ Million) & YoY Growth (2024-2034)
Figure 35. Maple Syrup Urine Disease Market Size (US$ Million) & YoY Growth (2024-2034)
Figure 36. Argininosuccinic Acidemia Market Size (US$ Million) & YoY Growth (2024-2034)
Figure 37. Citrullinemia Market Size (US$ Million) & YoY Growth (2024-2034)
Figure 38. Homocystinuria Market Size (US$ Million) & YoY Growth (2024-2034)
Figure 39. Global Amino Acid Metabolism Disorder Drug Market Size Share by Application: 2022 & 2034
Figure 40. North America Amino Acid Metabolism Disorder Drug Revenue Market Share by Application (2024-2034)
Figure 41. Europe Amino Acid Metabolism Disorder Drug Revenue Market Share by Application (2024-2034)
Figure 42. Asia-Pacific Amino Acid Metabolism Disorder Drug Revenue Market Share by Application (2024-2034)
Figure 43. Latin America Amino Acid Metabolism Disorder Drug Revenue Market Share by Application (2024-2034)
Figure 44. Middle East and Africa Amino Acid Metabolism Disorder Drug Revenue Market Share by Application (2024-2034)
Figure 45. Amino Acid Metabolism Disorder Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2024 VS 2022
Figure 46. Global Top 5 and Top 10 Players Amino Acid Metabolism Disorder Drug Market Share in 2022
Figure 47. North America Amino Acid Metabolism Disorder Drug Market Share by Country (2024-2034)
Figure 48. United States Amino Acid Metabolism Disorder Drug Market Size (2024-2034) & (US$ Million)
Figure 49. Canada Amino Acid Metabolism Disorder Drug Market Size (2024-2034) & (US$ Million)
Figure 50. Germany Amino Acid Metabolism Disorder Drug Market Size (2024-2034) & (US$ Million)
Figure 51. France Amino Acid Metabolism Disorder Drug Market Size (2024-2034) & (US$ Million)
Figure 52. U.K. Amino Acid Metabolism Disorder Drug Market Size (2024-2034) & (US$ Million)
Figure 53. Italy Amino Acid Metabolism Disorder Drug Market Size (2024-2034) & (US$ Million)
Figure 54. Russia Amino Acid Metabolism Disorder Drug Market Size (2024-2034) & (US$ Million)
Figure 55. Nordic Countries Amino Acid Metabolism Disorder Drug Market Size (2024-2034) & (US$ Million)
Figure 56. Asia-Pacific Amino Acid Metabolism Disorder Drug Market Share by Region (2024-2034)
Figure 57. China Amino Acid Metabolism Disorder Drug Market Size (2024-2034) & (US$ Million)
Figure 58. Japan Amino Acid Metabolism Disorder Drug Market Size (2024-2034) & (US$ Million)
Figure 59. South Korea Amino Acid Metabolism Disorder Drug Market Size (2024-2034) & (US$ Million)
Figure 60. Southeast Asia Amino Acid Metabolism Disorder Drug Market Size (2024-2034) & (US$ Million)
Figure 61. India Amino Acid Metabolism Disorder Drug Market Size (2024-2034) & (US$ Million)
Figure 62. Australia Amino Acid Metabolism Disorder Drug Market Size (2024-2034) & (US$ Million)
Figure 63. Latin America Amino Acid Metabolism Disorder Drug Market Share by Country (2024-2034)
Figure 64. Mexico Amino Acid Metabolism Disorder Drug Market Size (2024-2034) & (US$ Million)
Figure 65. Brazil Amino Acid Metabolism Disorder Drug Market Size (2024-2034) & (US$ Million)
Figure 66. Middle East & Africa Amino Acid Metabolism Disorder Drug Market Share by Country (2024-2034)
Figure 67. Turkey Amino Acid Metabolism Disorder Drug Market Size (2024-2034) & (US$ Million)
Figure 68. Saudi Arabia Amino Acid Metabolism Disorder Drug Market Size (2024-2034) & (US$ Million)
Figure 69. UAE Amino Acid Metabolism Disorder Drug Market Size (2024-2034) & (US$ Million)
Figure 70. Bottom-up and Top-down Approaches for This Report